Effect of feedback health education model on quality of life in patients with constipation-type irritable bowel syndrome / 中国实用护理杂志

ABSTRACT

Objective To explore the effect of feedback-based health education model on quality of life in patients with constipation- type irritable bowel syndrome. Methods 86 patients with constipation-type irritable bowel syndrome who were hospitalized in our hospital from December 2017 to December 2018 were selected. According to the method of random number, it was divided into control group (n=43) and observation group (n=43). The control group received routine care, and the observation group used the feedback education model for health education based on the control group. Symptom scores, anxiety and depression, and quality of life at admission and discharge were compared between the two groups. Results At the time of discharge, the abdominal pain, bloating, poor stool, and defecation in the control group were (1.74 ± 0.35), (1.37 ± 0.31), (1.23 ± 0.46), and (1.15 ± 0.21), respectively. The observation group were (1.02±0.21), (0.95±0.22), (1.02±0.35), and (0.81±0.12) points, respectively. The difference between the two groups was statistically significant (t=2.382-11.567, P<0.01 or 0.05). At the time of discharge, the HAMA score and HAMD score of the control group were (11.25±2.98) and (15.35± 4.01) points, respectively. The observation group was (7.57±2.77) and (9.35±2.33) points respectively. The difference between the two groups was statistically significant (t=5.931, 8.484, P<0.01). At the time of discharge, the physical function, role function, emotional function, and social function scores of the control group were (74.61 ± 5.09), (53.97 ± 3.78), (55.84 ± 5.17), and (45.66 ± 5.72) points, respectively. The observation groups were (78.91±4.78), (57.91±4.71), (60.79±5.94), and (49.91±4.91) points, respectively. The difference between the two groups was statistically significant (t=- 4.278-- 2.827, P<0.01). Conclusion Using the feedback-based education model to intervene in patients with constipation-type irritable bowel syndrome, it can help improve gastrointestinal symptoms, improve negative emotions, improve quality of life, and is worthy of clinical recommendation.